candesartan has been researched along with Weight Gain in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the effects of the angiotensin II receptor type 1 blocker candesartan on myocarditis injury in a murine model of acute myocarditis." | 7.74 | Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression. ( Fei, Y; Itoh, T; Iwai, K; Kanda, T; Kawaura, K; Matsumoto, M; Morimoto, S; Moriya, J; Nakahashi, T; Saegusa, S; Sumino, H; Takahashi, T; Yamakawa, J, 2007) |
| "We examined the effects of the angiotensin II receptor type 1 blocker candesartan on myocarditis injury in a murine model of acute myocarditis." | 3.74 | Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression. ( Fei, Y; Itoh, T; Iwai, K; Kanda, T; Kawaura, K; Matsumoto, M; Morimoto, S; Moriya, J; Nakahashi, T; Saegusa, S; Sumino, H; Takahashi, T; Yamakawa, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saegusa, S | 1 |
| Fei, Y | 1 |
| Takahashi, T | 1 |
| Sumino, H | 1 |
| Moriya, J | 1 |
| Kawaura, K | 1 |
| Yamakawa, J | 1 |
| Itoh, T | 1 |
| Morimoto, S | 1 |
| Nakahashi, T | 1 |
| Iwai, K | 1 |
| Matsumoto, M | 1 |
| Kanda, T | 1 |
1 other study available for candesartan and Weight Gain
| Article | Year |
|---|---|
Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression.
Topics: Adiponectin; Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; | 2007 |